News Releases

No Charge Program Uses High-Affinity Test to Detect SARS-CoV-2 Antibodies BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 11, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced details of a no charge antibody testing program

More details of the three-month program will be provided in the near future. BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 30, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced plans to create a program to offer total

Q2 revenue of $2.8 billion , down (4%) from $2.9 billion last year Q2 diluted EPS of $2.37 , up 23% from $1.93 last year; Q2 adjusted EPS of $2.57 , down (12%) from $2.93 last year Q2 free cash flow of $272 million , up from $168 million last year Processed more than 8.5 million molecular COVID-19

New Method Aims to Improve Efficiency of COVID-19 Testing, Optimize Testing Supplies and Increase Overall Capacity BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 25, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced it

LabCorp’s Employer Services wellness screenings support effective workplace re-entry and management CHICAGO, July 22, 2020 – Health, safety and wellness are top of mind for employers as they bring workers back to the office while navigating dynamic local conditions.

Reports utilize LabCorp testing data related to conditions that have co-morbidities with other serious diseases, including increased COVID-19 risk BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 9, 2020-- LabCorp (NYSE: LH), a leading global life sciences company deeply integrated in guiding patient care,

Convenient LabCorp At Home Service Aims to Help Patients Resume Health Care, Treatments, and Surgeries BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 7, 2020-- LabCorp (NYSE: LH) today launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital service aimed at helping

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 6, 2020-- LabCorp (NYSE: LH) will release its second quarter of 2020 financial results before the market opens on Tuesday, July 28, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

Advanced Analytics and Visualizations Empower Study Teams to Respond to Dynamic Environment, Manage Risk, Resume Studies and Safeguard Patients BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 29, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient

Neutralizing Antibody Assay Could Be Used to Assist in Development of COVID-19 Vaccines and Plasma-Based Treatments BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 25, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced the

BURLINGTON, N.C., June 16, 2020 — LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Dr. Brian Caveney, chief medical officer and president of LabCorp Diagnostics, was recognized by Modern Healthcare as one of this

Streamlining recruitment into studies to speed research BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 1, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, has created COVID-19

BURLINGTON, N.C. --(BUSINESS WIRE)--May 28, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of

LabCorp and other commercial labs will have the ability to perform more than 2 million tests per week by June INDIANAPOLIS , May 19, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG;OTCQX: RHHBY ) today announced its Elecsys® Anti-SARS-CoV-2 antibody test is live at more than 20 commercial and hospital lab

Employers Now Have Access to LabCorp’s High-Quality COVID-19 Testing Capabilities Including Its New Fingerstick Antibody Blood Test BURLINGTON, N.C. --(BUSINESS WIRE)--May 14, 2020-- LabCorp (NYSE: LH) announced today it is launching a new return to work service for employers. Many U.S.

Consumers Now Have Access to the At-Home Test Collection Kit Online with No Upfront Costs, In Addition to Healthcare Workers and First Responders BURLINGTON, N.C. --(BUSINESS WIRE)--May 12, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding

BURLINGTON, N.C. --(BUSINESS WIRE)--May 6, 2020-- LabCorp (NYSE: LH) today announced that members of the executive management team will participate in a virtual fireside chat at the Bank of America Securities 2020 Health Care Conference on Wednesday, May 13 , at 10:20 a.m. ET .

Expanding Access to Tests Through LabCorp’s Wide Network of Doctors, Healthcare Providers, and Now Online BURLINGTON, N.C. --(BUSINESS WIRE)--May 5, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that its COVID-19

BURLINGTON, N.C. --(BUSINESS WIRE)--May 5, 2020-- LabCorp (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 13 , at 9:00 a.m. Eastern Daylight Time via the company website at www.LabCorp.com . An archived replay of the audio webcast will be

Q1 revenue of $2.82 billion , up 1% over $2.79 billion last year Q1 diluted EPS of ( $3.27 ), which include goodwill and other asset impairments of $4.43 per share Q1 adjusted EPS of $2.37 , which were negatively impacted by an estimated $0.55 per share from the COVID-19 pandemic Q1 free cash flow

Locations include nearly 2,000 LabCorp patient service centers including more than 100 LabCorp at Walgreens locations, and thousands of physicians’ offices BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 27, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in

Tests Assist in Confirming the Presence of Antibodies to the Virus that Causes COVID-19 BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 22, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced it will expand serological

Initial Distribution Prioritized for Frontline Healthcare Workers and First Responders BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 21, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it has received an Emergency

Groundbreaking Registry Aims to Help Researchers Accelerate COVID-19 Diagnosis, Treatment and Prevention Strategies BURLINGTON, N.C. & ALPHARETTA, Ga. --(BUSINESS WIRE)--Apr. 9, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, and

LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2 and the related immune response to COVID-19   MENLO PARK, Calif., April 8, 2020 — Pacific